Jan 7, 2025 · Ansimar is used in the treatment and prevention of chronic obstructive pulmonary disease and asthma. Ansimar is a bronchodilator. It works by relaxing the muscles of the airways and widens airways. This makes breathing easier.

ANSIMAR sachets for pediatric use: the sachets, made of polythene-coated aluminum, are contained, together with the package leaflet, in a lithographed rigid, cardboard box.

Nov 8, 2024 · Doxofylline (Ansimar) generic is an antitussive, prescribed for asthma and Chronic Obstructive Pulmonary Disease (COPD).

Know about technical details of Ansimar like: chemical name, chemistry structure, formulation, uses, toxicity, action, side effects and more at Pharmacompass.com.

Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma [1] and COPD. [2] . Like theophylline, it is a xanthine derivative. [3][4] Doxophylline is used to treat chronic respiratory diseases such as asthma [1] and COPD. [2]

Jan 7, 2025 · Doxophylline is used to treat asthma, COPD and bronchospasm. Doxofylline is also used to associated treatment for these conditions: Bronchial Asthma, Chronic Obstructive …

The results of this study indicate that Doxofylline (ANSIMAR) is an effective and well-tolerated agent for Filipino patients with stable chronic obstructive pulmonary disease.

Doxofylline, also known as Ansimar and ABC-12-3, is a novel xanthine bronchodilator. Doxofylline's mechanism of action is related to the inhibition of phosphodiesterase activities, but it appears to have decreased affinities towards adenosine A1 and A2 receptors, which may account for its better safety profile.

Ansimar product overview.

Ansimar is used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma and chronic obstructive pulmonary disease (a group of lung diseases that includes chronic bronchitis and emphysema).